Live Attenuated Vaccines Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 17
SKU : PH2094
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
Who are the key players in the Live Attenuated Vaccines Market?
Major players are Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Sanofi, Astellas Pharma, CSL Limited, Serum Institute of India Pvt. Ltd., BioDiem, AstraZeneca, Emergent BioSolutions Inc, and Vivaldi Biosciences Inc.
Which region is expected to hold a significant position in the global live attenuated vaccines market ?
North America is expected to hold a significant position in the global live attenuated vaccines market share
Related Reports
pharmaceuticals

Vaccine Refrigerators Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 27
Starting from

$4350

pharmaceuticals

Hepatitis A Vaccine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 28
Starting from

$4350

pharmaceuticals

Vaccine Adjuvants Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 February 28
Starting from

$4350

pharmaceuticals

Toxoid Vaccine Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 January 17
Starting from

$4350

pharmaceuticals

Age Related Vaccine Adjuvant Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 08
Starting from

$4350

pharmaceuticals

Varicella Attenuated Live Vaccine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23
Starting from

$4350